Global Fund
latest news & developments
SA’s first batch of LEN jabs will arrive in February. Use Bhekisisa’s dashboard to find out who should get them
Who should get what slice of the pie once the medicine is available in public clinics? And are numbers alone what would drive decisions?
SA wants to make its own six-monthly HIV prevention jabs by 2027. But there’s a hitch
None of the companies that will be involved have a licence from the inventor of Lenacapavir, Gilead Sciences, to make the jab
The six-monthly anti-HIV jab could be in 360 clinics by February. Who should get the first doses?
The country’s medicines regulator Sahpra says it’s on track to announce its registration decision by the end of October
Two drugmakers will sell the 6-monthly anti-HIV jab for the price of the daily prevention pill
Hetero and Dr Reddy’s will be funded by the Gates Foundation and Unitaid to produce and sell the twice-a-year anti-HIV shot around R692 per person a year
People living with HIV in fear as impact of donor funding cuts begin to show in eSwatini
HIV prevention services have been heavily affected by the pause on the US President’s Emergency Plan for Aids in the country, with remote mobile clinics that served hard-to-reach…
Small win for activists, but SA’s HIV projects won’t reopen
The $400 million the United States congress removed from a list of funding programmes the Trump administration wants to cut doesn’t cancel the cuts to HIV and TB programmes made…
Mozambican children die after US funding cuts: Who bears responsibility?
The least the Trump administration could have done was provide ample warning that it was going to cut aid
SA gets R520 million to buy the twice-a-year anti-HIV jab – but there’s a snag
The country isn’t getting extra money from the Global Fund to Fight Aids, TB and Malaria; it has to use cash from a grant it has already been awarded and was cut by 16% in June
The Global Fund has just made history – now it must start a revolution
Africa’s first locally made HIV treatment is more than a milestone, it’s a political, economic and moral turning point in the fight for health sovereignty
How this Limpopo NGO prepared for Trump’s funding cuts
The Anova Health Institute, which received the lion’s share of the US President’s Emergency Plan for Aids funding in South Africa, had its support halted in February along with…
The six-monthly anti-HIV jab could end Aids in SA by 2032
A modelling study released in March gives a clue at which price the jab, lenacapavir, would be worth the health department’s while
The Global Fund will roll out the twice-yearly anti-HIV jab — with or without Pepfar
In December, the Global Fund and the US President’s Emergency Plan for Aids Relief committed to funding the roll-out of lenacapavir in countries they support
Trump’s funding cuts hit HIV, GBV services hard
The US president’s cutting of financial support has cut life-saving treatment for many in SA
Some Pepfar projects can now restart in full, without a waiver
A federal judge has enforced a temporary restraining order blocking Donald Trump from freezing federal grants
UPDATE | Embassy confirms Pepfar projects will restart, despite Trump aid ban
Such programmes still qualify for a limited waiver, which will expire towards the end of April, but only for approved activities